FCGR1A and cancer: Vβ8 antibody administration in conjunction with CD64 IR T cell transfer was required to prevent tumor Jurkat cancer cell outgrowth; Vβ8 antibody in conjunction with untransduced T cells had no statistically significant impact (Figure 3B, p = 0.13), demonstrating that, in the absence of CD64 IR T cells, the Vβ8 antibody was ineffective.